Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Finasteride has various adverse effects, including sexual dysfunction and mental health issues, which vary by age and gender.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Some medications can help increase sexual desire and function in women.

A new acne cream effectively reduced acne in trials and awaits FDA approval.

The FDA approved using Cialis with Proscar for better treatment options.

The FDA did not approve a testosterone drug because of safety concerns.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

Apremilast shows promise for several skin conditions but needs more research.

The FDA should use negotiated rulemaking to improve generic drug safety regulations.

Five FDA-approved drugs may help block COVID-19 virus entry.

The FDA struggles to regulate hair loss supplements due to a law allowing unproven claims.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Pranlukast and mirabegron may work as new diabetes drugs.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

PRP treatments for hair loss need standard protocols to be reliable.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

New technologies replicate human skin for testing without animals.

Finasteride and testosterone are the drugs most linked to male infertility, but many other potential drugs may be under-reported.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.